SCHEMBL19929823

SCHEMBL19929823

COC(=O)c1cc(C)cc2oc(-c3ccc(OC)cc3)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.54
▸ MAOB P27338 7/20 0.52
▸ KCNA5 P22460 2/20 0.51
▸ KCNH2 Q12809 2/20 0.51
▸ TP53 P04637 4/20 0.50
▸ CYP3A4 P08684 4/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ CYP2C19 P33261 3/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ TNKS O95271 2/20 0.50
▸ TNKS2 Q9H2K2 1/20 0.50
▸ KDM4E B2RXH2 5/20 0.48
▸ MAPT P10636 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ HSD17B10 Q99714 3/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19934926 0.91 MAOB (0.56) MAOBKCNA5KCNH2TP53CYP3A4
SCHEMBL28670379 0.90 ADORA3 (0.56) ADORA3MAOBKCNA5KCNH2TP53
SCHEMBL28660360 0.84 TNKS (0.54) ADORA3MAOBKCNA5KCNH2TP53
SCHEMBL28654878 0.79 CA12 (0.49) ADORA3MAOBKCNA5KCNH2TP53
SCHEMBL3102333 0.78 ALDH1A1 (0.62) MAOBCYP3A4CYP2C9CYP2C19MEN1
SCHEMBL28663810 0.76 ALDH1A1 (0.64) TP53CYP3A4MEN1KMT2AKDM4E
SCHEMBL28655613 0.75 MAOB (0.50) MAOBMEN1KMT2ATNKSTNKS2
SCHEMBL28929133 0.75 MAOB (0.48) ADORA3MAOBTNKSKDM4EMAPT
SCHEMBL28655615 0.74 DHODH (0.53) MAOBMEN1KMT2AKDM4EMAPT
SCHEMBL19929834 0.74 MAPT (0.41) KMT2AKDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 ADORA3 1983/4885MAOB 2097/4885KCNA5 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback